Monoclonal antibodies for treatment of cancer

Details for Australian Patent Application No. 2008226001 (hide)

Owner Johannes Gutenberg-Universitat Mainz Ganymed Pharmaceuticals AG

Inventors Koslowski, Michael; Tureci, Ozlem; Sahin, Ugur

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008226001

PCT Pub. Number WO2008/110379

Priority 07 005 258.4 14.03.07 EP; 60/894,860 14.03.07 US

Filing date 14 March 2008

Wipo publication date 18 September 2008

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/110379 Priority application(s): WO2008/110379

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008226013-Distribution cabinet comprising a plurality of inner bodies

2008225994-Monoclonal human tumor-specific antibody